Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Neurodiagnostics LLC is managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The busiest examiner for this portfolio is NICOL, ALEXANDER W, who is responsible for 1 pending office action. The data shows 1 distinct examiner and 1 distinct art unit, indicating that the current prosecution activity is limited to a single examiner's oversight.
This concentration allows for a focused prosecution strategy directed at a single examiner's preferences. The presence of 1 distinct art unit suggests that the subject matter is highly specialized within a single supervisory group. Practitioners can expect a consistent application of procedural rules given the singular nature of the current examination path.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| No statute on record | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NICOL, ALEXANDER W | 1 | 42.9% | +43.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18062642 | Lymphocyte-Based PKCe Test for Alzheimer's Disease | NICOL, ALEXANDER W | 105d overdue |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18062642 | Lymphocyte-Based PKCe Test for Alzheimer's Disease | NICOL, ALEXANDER W | 1634 | — | Final Rejection | 105d overdue | Pending | Dec 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial